Related references
Note: Only part of the references are listed.Pharmacologic Treatment of Motor Symptoms Associated with Parkinson Disease
Werner Poewe et al.
NEUROLOGIC CLINICS (2020)
Recent Clinical Advances in Pharmacotherapy for Levodopa-Induced Dyskinesia
Thomas Mueller et al.
DRUGS (2019)
Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
Tina deVries et al.
NEUROLOGY AND THERAPY (2019)
Acute respiratory distress syndrome: A rare presentation of amantadine toxicity
Juan Cattoni et al.
AMERICAN JOURNAL OF CASE REPORTS (2014)
Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury
Joseph T. Giacino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients
LA Keyser et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
